Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
European Journal of Cancer & Clinical Oncology
|
January 1, 1989
In vitro lymphocyte response to autologous melanoma: clues in designing new adoptive immunotherapy protocols
G Parmiani, L Rivoltini
Current Opinion in Oncology
|
December 1, 1991
Biologic agents as modifiers of chemotherapeutic effects
G Parmiani, L Rivoltini
Tumori
|
February 24, 2001
Cancer vaccines
M Carrabba, G Parmiani, L Rivoltini
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Vaccination of patients with solid tumours
G Parmiani, L Pilla, C Castelli, et al.
Immunology Letters
|
September 21, 2000
Cytokines in cancer therapy
G Parmiani, L Rivoltini, G Andreola, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1997
T-cell recognition of melanoma antigens and its therapeutic applications
C Castelli, L Rivoltini, A Mazzocchi, et al.
Advances in Experimental Medicine and Biology
|
January 5, 2002
T cell response to tumor antigens and its therapeutic use in cancer patients
G Parmiani, C Castelli, P Dalerba, et al.
International Journal of Cancer
|
May 15, 1989
Generation and partial characterization of melanoma sublines resistant to lymphokine activated killer (LAK) cells. Relevance to doxorubicin resistance
L Rivoltini, C Gambacorti-Passerini, R Supino, et al.
The International Journal of Biological Markers
|
July 1, 1992
CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytes
L Rivoltini, G Cattoretti, F Arienti, et al.
Cancer Research
|
June 1, 1991
Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb
C Melani, L Rivoltini, G Parmiani, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
European Journal of Cancer & Clinical Oncology
|
January 1, 1989
In vitro lymphocyte response to autologous melanoma: clues in designing new adoptive immunotherapy protocols
G Parmiani, L Rivoltini
Current Opinion in Oncology
|
December 1, 1991
Biologic agents as modifiers of chemotherapeutic effects
G Parmiani, L Rivoltini
Tumori
|
February 24, 2001
Cancer vaccines
M Carrabba, G Parmiani, L Rivoltini
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Vaccination of patients with solid tumours
G Parmiani, L Pilla, C Castelli, et al.
Immunology Letters
|
September 21, 2000
Cytokines in cancer therapy
G Parmiani, L Rivoltini, G Andreola, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1997
T-cell recognition of melanoma antigens and its therapeutic applications
C Castelli, L Rivoltini, A Mazzocchi, et al.
Advances in Experimental Medicine and Biology
|
January 5, 2002
T cell response to tumor antigens and its therapeutic use in cancer patients
G Parmiani, C Castelli, P Dalerba, et al.
International Journal of Cancer
|
May 15, 1989
Generation and partial characterization of melanoma sublines resistant to lymphokine activated killer (LAK) cells. Relevance to doxorubicin resistance
L Rivoltini, C Gambacorti-Passerini, R Supino, et al.
The International Journal of Biological Markers
|
July 1, 1992
CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytes
L Rivoltini, G Cattoretti, F Arienti, et al.
Cancer Research
|
June 1, 1991
Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb
C Melani, L Rivoltini, G Parmiani, et al.
Page
of 9